The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.

Say goodbye to the classic ClinicalTrials.gov!

The classic ClinicalTrials.gov website will be retired on June 25, 2024. Please use the modernized ClinicalTrials.gov. For more information, see ClinicalTrials.gov Modernization.

Key Record Dates

ClinicalTrials.gov Identifier:	NCT04739527
Brief Title:	Phase 1 Study to Evaluate the Safety, Feasibility and Immunogenicity of an Allogeneic, Cell-based Vaccine (DCP-001) in High Grade Serous Ovarian Cancer Patients After Primary Treatment (ALISON)

First Submitted :	January 8, 2021
First Submitted that Met QC Criteria :	February 3, 2021
First Posted :	February 4, 2021

Last Update Submitted that Met QC Criteria :	November 25, 2022
Last Update Posted :	November 28, 2022

To Top